← FDA Drug Approvals (Drugs@FDA)

IOMERVU

NDA · New Drug Application · Sponsor: BRACCO · Approved 2024-11-27

Drug application

FDA Application #

NDA216017

Application type

New Drug Application

Brand name

IOMERVU

Generic name

Iomeprol

Active ingredients

IOMEPROL

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

BRACCO

First approval

2024-11-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown